Alvotech SA reported total revenues of $420.0 million for the first nine months of 2025, marking a 24% increase compared to the same period last year. Product and service revenue rose by 85% to $237.0 million, while license and other revenue decreased by 13% to $182.0 million. Adjusted EBITDA was $68.0 million, a 21% decline, attributed to increased R&D investments and lower licensing revenues. The company recorded a net profit of $136.5 million, or $0.47 per share, reversing a net loss of $164.9 million in the prior-year period. Finance income totaled $170.7 million, mainly due to favorable revaluation of derivative liabilities. Alvotech continued to streamline its capital structure, recording a $17.7 million net gain from debt modifications and consolidations in June 2025. Q2 2024 was the strongest quarter, with Q4 expected to lead in 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001138541-en) on November 12, 2025, and is solely responsible for the information contained therein.
Comments